73899-15-7

Basic information

• Product Name: Silane, [2-(4-bromophenyl)ethoxy](1,1-dimethylethyl)dimethyl-
• CAS NO: 73899-15-7
• Molecular Formula: C14H23BrOSi
• Molecular Weight: 315.326
• Mol File: 73899-15-7.mol
• Article Data: 27

Chemical Properties

• CAS DataBase Reference: Silane, [2-(4-bromophenyl)ethoxy](1,1-dimethylethyl)dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Silane, [2-(4-bromophenyl)ethoxy](1,1-dimethylethyl)dimethyl-(73899-15-7)
• EPA Substance Registry System: Silane, [2-(4-bromophenyl)ethoxy](1,1-dimethylethyl)dimethyl-(73899-15-7)

Safety Data

• Hazardous Substances Data: 73899-15-7(Hazardous Substances Data)

Upstream product

• 1878-68-8 2-(4-bromophenyl)-acetic acid 
• 288-32-4 1H-imidazole 
• 4654-39-1 4-bromophenethanol 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 73899-16-8 1-<4-<2-(tert-butyldimethylsilyloxy)ethyl>phenyl>-2,2,2-trifluoro-1-ethanone 
• 1353660-68-0 C₃₉H₅₈N₄O₈Si 
• 1353660-72-6 C₃₈H₅₆N₄O₈Si 
• 1353660-78-2 C₅₃H₈₂N₄O₁₀Si 
• 167264-35-9 (E)-methyl 3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)acrylate 
• 1353660-33-9 (2S,3R)-methyl 3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)-2,3-dihydroxypropanoate 
• 1353660-41-9 (2S,3S)-methyl 3-azido-3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)-2-hydroxypropanoate 
• 1353660-50-0 (2S,3S)-methyl 3-azido-3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)-2-methoxypropanoate 
• 1353660-59-9 (2S,3S)-methyl 3-amino-3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)-2-methoxypropanoate 
• 167264-41-7 4-[2-(t-butyldimethylsilyloxy)ethyl]benzaldehyde 

Relevant articles and documents

Synthesis of an [125I]-labelled derivative of MK-571, a tool for LTD4 receptor studies

An [125I]-labelled derivative of MK-571 2 was synthesized from the arylstanne derivative 11 in 50% radiochemical yield. Compound 2 is a useful tool for LTD4 receptor studies. The arylstanne intermediate 11 was obtained from the coupl

Synthesis of some nitroimidazole substituted boronic acids: Precursors to technetium-99m complexes with potential for imaging hypoxic tissue

A number of nitroimidazole substituted alkyl and aryl-boronic acids were synthesized as precursors to technetium-99m complexes under investigation as potential imaging agents of hypoxia. Compounds were prepared with nitro group either in the 2- or 4-posit

Nitroxide derivative of ROCK kinase inhibitor

The invention provides a small molecular compound of a NO donor. The small molecular compound is characterized in that the small molecular compound is a compound shown represented by structural formula I shown in the description, or a stereoisomer, a geometrical isomer, a tautomer, a racemate, a deuterated isotope derivative, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof; and in the formula I, ring A is a substituted or unsubstituted heteroaromatic ring, X is selected from (CH2)n, n is selected from 0, 1, 2 and 3, R is a substituent group of terminal -O-NO2, R is selected from hydrogen, a hydroxyl group, halogen, an amino group, a cyano group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group and a substituted or unsubstituted heteroalkyl group, and R and R are respectively and independently selected from hydrogen, a substituted or unsubstituted alkyl group, a substituted or unsubstituted naphthenic base or an amino protecting group, or R and R are connected to form a substituted or unsubstituted cyclic heteroalkyl group. The compound has a high-activity inhibition effect on ROCK kinase.

ANTIMICROBIAL COMPOUNDS AND METHODS

The invention is directed to compounds that are active as antibacterial agents. The invention compounds are active against gram-positive and gram-negative bacteria and can be used to treat infections caused by gram-positive and gram-negative bacteria. Also disclosed are processes and intermediates for making the compounds.